According to SNS Insider’s research, the recombinant vaccines market is poised for substantial growth due to technological advancements, safety concerns, the impact of global pandemics, and the need for more effective vaccines.Pune, Oct. 03, 2023 (GLOBE NEWSWIRE) -- “The SNS Insider report states that the Recombinant Vaccines Market reached USD 9.18 billion in 2022 and is projected to attain USD 21.46 billion by 2030, with a compound annual growth rate (CAGR) of 11.2% during the forecast period
read more..